发明名称 |
ORAL COMPLEX FORMULATION COMPRISING OMEGA-3 FATTY ACID AND HMG-COA REDUCTASE INHIBITOR WITH IMPROVED STABILITY -3 HMG-COA |
摘要 |
The present invention relates to an oral complex formulation comprising omega-3 fatty acid or its derivatives encapsulated in a hard or soft capsule containing sorbitol and sorbitan, as well as an HMG-CoA reductase inhibitor. The formulation of the present invention comprising omega-3 fatty acid encapsulated with sorbitol and sorbitan provides better prevention related materials from being formed, leading to improved long-term storage stability. The oral complex formulation of the present invention also can raise the serum HDL-cholesterol level, while reducing both LDL-cholesterol and TG levels. The oral complex formulation of the present invention is useful for treatment of hyperlipidemia. |
申请公布号 |
HK1199396(A1) |
申请公布日期 |
2015.07.03 |
申请号 |
HK20140112885 |
申请日期 |
2014.12.24 |
申请人 |
HANMI PHARM. CO. LTD. |
发明人 |
KIM, JIN CHEUL;KIM, JAE HO;YOON, EUN JIN;KIM, YONG IL;PARK, JAE HYUN;WOO, JONG SOO |
分类号 |
A61K |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|